98%
921
2 minutes
20
There is increasing recognition of the importance of human-animal interaction (HAI) research in the assessment of animal welfare. This is partly reflected by the appearance of increasing animal-visitor interaction (AVI) publications in zoos. Early AVI publications primarily focused on primates and the impact of visitors on animals (visitor effects), with most identifying negative welfare impacts. This review aims to identify trends and changes in the key factors of AVIs (e.g., types of interactions measured; taxa studied; welfare impact). Covidence online software and PRISMA were used to screen papers and extract data. A total of 157 papers comprising 314 studies were included. AVI publications have increased in the last two decades, with a large increase in publications since 2020. Most publications have focused on visitor effects, as opposed to the impact of animals on visitors (visitor experiences). Earlier visitor effect studies mostly focused on primates, while more recent studies have primarily focused on non-primate species. Excluding studies categorized as neutral, there were more visitor effect studies with measures focused on negative than positive welfare impacts. However, the last decade and a half has seen a substantial increase in visitor effect studies measuring positive welfare impacts. These results are discussed in reference to growing changes in the types of studies, species, and outcomes measured in AVIs. In addition, we consider the future of AVI research, including a growing need for and consideration of standardized welfare assessments, the increased use of experimental control, and AVIs that equally promote visitor education and positive animal welfare.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12248964 | PMC |
http://dx.doi.org/10.3390/ani15131924 | DOI Listing |
Cureus
August 2025
Anaesthesia and Surgical Intensive Care, Changi General Hospital, Singapore Health Services, Simei, SGP.
Effective airway topicalization is essential for awake tracheal fiberoptic intubation (ATI) in patients with a difficult airway. Traditional methods often result in inadequate anesthesia at the laryngeal inlet, leading to patient discomfort, procedural difficulty, and excessive local anesthetic (LA) use. This case series introduces a novel, resource-efficient topicalization technique using standard operating theatre equipment.
View Article and Find Full Text PDFBiomedicines
July 2025
Institute of Bioengineering, Miguel Hernández University, 03202 Elche, Spain.
: COVID-19, caused by the SARS-CoV-2 virus, has infected over 777 million individuals and led to approximately 7 million deaths worldwide. Despite significant efforts to develop effective therapies, treatment remains largely supportive, especially for severe complications like acute respiratory distress syndrome (ARDS). Numerous compounds from diverse pharmacological classes are currently undergoing preclinical and clinical evaluation, targeting both the virus and the host immune response.
View Article and Find Full Text PDFAntibiotics (Basel)
August 2025
Infectious Diseases Clinic, Via Conca 71, 60126 Torrette, Italy.
Unlabelled: Ceftazidime-avibactam (CAZ-AVI) is a second-generation intravenous β-lactam/β-lactamase inhibitor combination. In recent years, substantial evidence has emerged regarding the efficacy and safety of CAZ-AVI. However, data on its use in critically ill patients remain limited.
View Article and Find Full Text PDFPopul Health Metr
August 2025
International UNESCO center for Health-Related Basic Sciences and Human Nutrition, Mashhad University of Medical Sciences, Mashhad, Iran.
Introduction: Dyslipidemia as a modifiable risk factor for chronic non-communicable diseases has become a worldwide concern. We aim to explore different anthropometric measures as predictors of dyslipidemia using various machine learning methods.
Method: From the baseline of the Mashhad Stroke and Heart Atherosclerotic Disorder (MASHAD) study, a total of 9,640 participants were included in the analysis.
Sci Rep
August 2025
Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Bursa Uludağ University, Bursa, Turkey.
Carbapenem-resistant Enterobacterales (CRE), particularly carbapenem-resistant Klebsiella pneumoniae (CRKP) and carbapenem-resistant Escherichia coli (CREC), are significant pathogens causing healthcare-associated infections. This retrospective study assesses the effectiveness of ceftazidime-avibactam (CAZ/AVI) in achieving perianal swab (PAS) negativity compared to other treatments, including colistin, polymyxin B, meropenem, and combinations with fosfomycin. We retrospectively analyzed 147 CRE-colonized patients (76 females) screened with PAS samples from January 14, 2021, to April 27, 2024.
View Article and Find Full Text PDF